Alfredo Nicosia

  • PDF

Alfredo was a co‐founder of Okairos and served as the company’s Chief Scientific Officer, contributing to

the preclinical and clinical development of a number of vaccines and monoclonal antibodies against

infectious diseases and cancer.

Alfredo’s experience includes the positions of senior director of the Viral Diseases Vaccine program at

Istituto di Ricerche di Biologia Molecolare (IRBM), staff scientist at the European Molecular Biology

Laboratory (EMBL) in Heidelberg, Germany and project leader at the Sclavo Research Centre in Siena, Italy.

He has also published articles in leading journals on a range of subjects, including viral and bacterial

infection and vaccines.

Alfredo holds a degree in chemistry from the University of Rome, Italy.